EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

ageas SA/NV (FO4N) fair value: what the stock is really worth

As of Oct 2, 2026: fair value of ageas SA/NV €62.66, price €73.25, upside -14.5%, quality 56 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? No
  2. Good quality? Yes
  3. Add to watchlist

Financial Services · DE · Home Belgium

AS ageas SA/NV logo Thin data Oct 3, 2026

ageas SA/NV

FO4N · HA

Overvalued / MonitorQuality is not strong enough to offset the price risk.

!Fair value €62.66 · Overvalued (−14.5%)
!Quality 56/100
!Weak Growth (revenue 5y −4.9 %/yr)
✓Solidly profitable · 18.9% net margin (FY2025)
✓Moderate debt · generates free cash flow
!Mixed vs. peers (5/12)
✓Wide moat 67/100
!Insider activity 40/100
!Evidence only low, so the estimate is less certain
!Weak on valuation: 14 out of 100

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

€76.95 €26.87 Fair Value €62.66 Jun 2021 Oct 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 3, 2026.

How to read this chart

60‑month range €26.87 – €76.95 · fair‑value band €52.40 – €86.07 · the €73.25 price screens above the €62.66 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Oct 3, 2026.

Follow ageas SA/NV in your weekly email

Every Wednesday you see whether ageas SA/NV is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

There is no Profile data available for FO4N.HA.

Stock analysis

ageas SA/NV (FO4N) currently trades at €73.25, while our model-based Fair Value estimate is €62.66, 14.5% below the price, so the stock looks overvalued today.

Show more

Valuation

Bull case: the Multiples group reads highest at a median of €114.09 per share, and 3 of the 4 models we run sit above the €73.25 price.

Bear case: the Asset-Based group reads lowest at €54.60, and 1 of the 4 models stay below the price. Evidence for this calculation is low.

Scenario range: €52.40 (bear) to €86.07 (bull), the price of €73.25 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 56/100 (solid quality), in the Financial Services sector.

Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.

ageas SA/NV reported revenue of €9.0B in FY2025 versus €12.9B in FY2021, a compound −8.5%/yr. Reported net income was €1.7B in FY2025, compounding +19.3%/yr from FY2021.

Key figures

Market cap €14.0B · Dividend yield 7.7% · Net margin 18.9% · Free cash flow €2.6B · Net debt €3.2B.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 52 out of 100 (low confidence).

What moves the price

The share trades about 5% below its 52-week high and 37% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Financial Services peers we cover trades at −22% fair-value upside, at −14%, FO4N screens cheaper than that median.

Fair Value models

Bear €52.40 Fair Value €62.66 Bull €86.07
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
Residual Income €90.66 €112.54 €162.70 73
P/E Multiple €144.08 €192.10 €240.13 63
P/B Multiple €85.56 €114.09 €142.61 55
All 4 models by family
Multiples
P/E Multiple €144.08 €192.10 €240.13 63
P/B Multiple €85.56 €114.09 €142.61 55
Asset-Based
NCAV (Graham) €40.74 €54.60 €81.49 54
Economic Profit
Residual Income €90.66 €112.54 €162.70 73

Open the full fair value analysis →

Notify me when FO4N reaches fair value

Put FO4N on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 56/100

Of which business quality 51 · Market factors (momentum, volatility) 76

Profitability 43
Margins and returns on capital today
Quality Growth 45
Are margins and returns improving?
Cashflow 92
Earnings quality: real cash, not paper profit
Fin. Strength 10
Balance sheet, leverage, solvency risk
Investment 74
Disciplined investing over empire-building
Low Volatility 91
Calm price path (market factor)
Momentum 67
Price trend over the last 3–12 months (market factor)
52W Momentum 75
Distance to the 52-week high (market factor)
Net Issuance 52
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 40/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
+4.7%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+22.7%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−4.9%
Start year 2020 (pandemic)
Revenue growth 7 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−2.8%
What shareholders gained per year (last 5 years) (mathematically smoothed) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Smoothed = median of all growth paths between the years of the window (trend line on the logarithm of earnings per share): a single extreme year cannot distort the rate. The reported figure stays in the tooltip.
+15.7%
Earnings growth per share plus dividend.
Earnings per share, growth per year+8.0%
Dividend (yield on the price)7.7%
2025 sits 50% above its own trend. The rate follows the median trend of the last 5 years, not that single year.
⚠ Revenue per share shrinking 5.3%/yr over ~5Y (margin trend unclear) ⓘStructural-decline marker: revenue PER SHARE has fallen over the last decade (robust median trend, not a single year). Backtested across 2005 to 2017, such businesses trailed the market by about 2.5 percentage points per year. Display only: it does not change the fair value or the quality score.

Growth Forecast

Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−10.8%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (euro area: IMF forecast 2.2% a year to 2030, 2.6% from 2016 to 2025) that is about −12.7% a year for the price.

FO4N screens overvalued: fair value 14% below the price. Compare with Allianz SE →

Earlier news

News mood ⓘNews mood, the average tone of recent news (67 articles), rated against how stocks are usually covered. 🚀 Hype = unusually upbeat · 🙂 Positive = above average · 😐 Neutral = typical · 🙁 Negative = below average · 😨 Very negative = unusually downbeat. It reflects the tone of coverage, not our valuation. Hype
Recent news coverage is unusually upbeat, far more positive than stocks are typically covered.

Compare ageas SA/NV with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Insurance - Diversified · 82 stocks

Beats the industry median on 5/11 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 54 · Below median
Fair Value upside −14.5% · Above median
Profitability
Return on assets 0.0% · Bottom 25%
Net margin (TTM) 18.9% · Top 25%
Operating margin (TTM) 0.0% · Bottom 25%
Growth and dividend
Revenue growth 0.0% · Below median
Dividend yield (TTM) 7.7% · Top 25%
Balance sheet
Debt / equity 0.67× · Highest 25%

Valuation Multiplesvs Insurance - Diversified median · lower = cheaper

P/B 1.66× · Pricier than median
P/FCF 6.1× · Cheaper than median
PEG 0.77× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)14 · sector 8
FUTURE (revenue growth)0 · sector 39
PAST (return on equity)0 · sector 52
HEALTH (low debt)67 · sector 89
DIVIDEND (yield)100 · sector 75

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Insurance - Diversified stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Allianz SE ALV €412.00 €229.84 −44%
Zurich Insurance Group ZURN CHF 563.60 CHF 328.80 −42%
AXA SA CS €41.90 €36.28 −13%
Assicurazioni Generali S.p.A G €42.75 €10.92 −74%
Sun Life Financial Inc SLF $79.48 $41.03 −48%
American International Group AIG $74.17 $71.58 −3%
Talanx AG TLX €117.40 €91.88 −22%
The Hartford Insurance Group HIG $126.04 $115.03 −9%
Arch Capital Group ACGL $94.26 $127.51 +35%
Swiss Life Holding SLHN CHF 891.00 CHF 413.93 −54%

Explore undervalued stocks

More undervalued Financial Services stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "ageas SA/NV Fair Value". https://www.fairvalue-calculator.com/stock/FO4N

Frequently asked questions

Is ageas SA/NV (FO4N) overvalued or undervalued?
As of Oct 3, 2026, our model estimates a fair value of €62.66 versus a price of €73.25, about −14% upside (overvalued).
What is the fair value of FO4N?
Our model-based fair value for ageas SA/NV is €62.66 (as of Oct 3, 2026), built from audited fundamentals. The current price: €73.25.
What is the quality score of FO4N?
ageas SA/NV has a Quality Score of 56/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for ageas SA/NV (FO4N)?
Our model-based price target is the fair value of €62.66 (as of Oct 3, 2026) from 4 valuation models. Cautious scenario €52.40, optimistic scenario €86.07. It is a calculation from audited fundamentals, not an analyst target.
What is the ageas SA/NV stock forecast for 2026?
Our models put fair value at €62.66, about −14% upside versus a price of €73.25 (overvalued). Cautious scenario €52.40, optimistic scenario €86.07. The calculation is refreshed regularly with new filings.
Does ageas SA/NV pay a dividend?
ageas SA/NV currently shows a dividend yield of about 7.74% relative to its recent price (as of Oct 3, 2026).
What growth is priced into ageas SA/NV (FO4N)?
For today's price to be fair in a discounted-cash-flow model, ageas SA/NV would have to grow free cash flow by -10.8 % per year for five years (discount rate 9.5 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew -4.9 % per year. As of Oct 3, 2026.
What discount rate (WACC) does the fair value of FO4N use?
Our models discount ageas SA/NV at 9.5 %: a base by market capitalisation (mid), country premium for Germany. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For ageas SA/NV that is -10.8 % per year a year over ten years, using the same discount rate (9.5 %) and the same formula as our fair value.
How much growth has ageas SA/NV (FO4N) delivered so far?
Over the past 5 years revenue at ageas SA/NV grew -4.9 % a year. The price currently implies -10.8 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of ageas SA/NV (FO4N) growing?
The median revenue growth in the sector is +7.8 % a year. That is the yardstick for the growth priced into ageas SA/NV (-10.8 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of ageas SA/NV (FO4N)?
The free-cash-flow yield on the price is 18.44 %: that much free cash flow ageas SA/NV produces per unit of market value. When it exceeds the discount rate of our models (9.5 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of ageas SA/NV (FO4N)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For ageas SA/NV it is €62.66 per share (as of Oct 3, 2026), against a price of €73.25. It is the blended result of 4 valuation models (cash flow, earnings, asset, dividend).
Is ageas SA/NV stock overvalued or undervalued in 2026?
As of Oct 3, 2026, FO4N trades above its calculated fair value: price €73.25, fair value €62.66, a gap of about −14% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of FO4N?
No. The price is what the market pays today (€73.25); the fair value is what the company's own numbers justify (€62.66). For ageas SA/NV the two are €10.59 per share apart. That gap is exactly why we show both numbers side by side.
How much is ageas SA/NV worth?
The market values ageas SA/NV at about €14.0B (market capitalisation, as of Oct 3, 2026). Per share that is €73.25; our models calculate a fair value of €62.66 per share.
What do the bullish and bearish scenarios say about FO4N?
Our models span a range for ageas SA/NV: cautious scenario €52.40, base €62.66, optimistic €86.07 per share (as of Oct 3, 2026, price €73.25). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the PEG ratio of FO4N?
The PEG ratio of ageas SA/NV is 0.77 (P/E divided by earnings growth, as of Oct 3, 2026). That is below 1, so growth is priced more cheaply than the earnings multiple alone suggests.
How solid is the balance sheet of ageas SA/NV (FO4N)?
Balance-sheet figures for ageas SA/NV (as of Oct 3, 2026): debt of 0.67 per unit of equity. They feed the Quality Score of 56/100, which measures business quality independently of the share price.
How far is FO4N from its 52-week high?
ageas SA/NV trades at €73.25, about 5% below its 52-week high of €76.95 and 37% above the low of €53.45 (as of Oct 2, 2026). Distance from the high says nothing about value: that is what the fair value of €62.66 is for.
Which stocks are comparable to ageas SA/NV?
From the same area (Financial Services) we also value Allianz SE, Zurich Insurance Group, AXA SA, Assicurazioni Generali S.p.A, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is ageas SA/NV stock attractive at the current price?
The data as of Oct 3, 2026: price €73.25, calculated fair value €62.66 (−14%), Quality Score 56/100, from 4 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of FO4N calculated?
We run ageas SA/NV through 4 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of €62.66, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. ageas SA/NV itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of ageas SA/NV (FO4N)?
The closing price on Oct 2, 2026 was €73.25. Our model-based fair value is €62.66, about −14% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with ageas SA/NV right now?
Solid but not exceptional quality (56/100) and above fair value, neither a clear bargain nor a standout compounder. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual. For a financial, book-value and earnings-based methods matter more than a cash-flow DCF, which fits banks and insurers poorly.

Key figures of ageas SA/NV

How large is the market capitalisation of ageas SA/NV (FO4N)?
The market capitalisation of ageas SA/NV is €14.0B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the dividend yield of ageas SA/NV (FO4N)?
The dividend yield of ageas SA/NV is 7.7%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of ageas SA/NV (FO4N)?
The net margin of ageas SA/NV is 18.9% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
How much net debt does ageas SA/NV (FO4N) carry?
The net debt of ageas SA/NV is €3.2B (fiscal year 2025, ≈ 1.2 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch ageas SA/NV in the live analysis

One click puts ageas SA/NV on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.